Felipe Duran - 13 Feb 2023 Form 3 Insider Report for iBio, Inc. (IBIO)

Signature
/s/ Felipe Duran
Issuer symbol
IBIO
Transactions as of
13 Feb 2023
Net transactions value
$0
Form type
3
Filing time
14 Feb 2023, 08:14:48 UTC
Next filing
03 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IBIO Common Stock (RSU) 2,133 13 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IBIO Stock Option (Right to Buy) 13 Feb 2023 Common Stock 2,800 $32.25 Direct F2
holding IBIO Stock Option (Right to Buy) 13 Feb 2023 Common Stock 1,000 $31.50 Direct F2
holding IBIO Stock Option (Right to Buy) 13 Feb 2023 Common Stock 12,000 $7.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 2,133 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 2,133 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. These RSUs will vest in even increments on the first three anniversaries of grant, subject to the conditions of the Plan and grant agreement.
F2 25% of options granted will vest one year following the grant date; and after one year following the grant date, 6.25% of the options granted will vest for each additional 3 months of employment, subject to the conditions of the Plan and grant agreement.